200 related articles for article (PubMed ID: 3165528)
21. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
[TBL] [Abstract][Full Text] [Related]
22. Subtypes of intestinal metaplasia and gastric carcinoma. A clinicoendoscopic follow-up of 112 cases.
Fang DC; Liu WW
Chin Med J (Engl); 1991 Jun; 104(6):467-71. PubMed ID: 1874022
[TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
[TBL] [Abstract][Full Text] [Related]
24. [Tumor markers in biliary tract cancer].
Najima M; Okusaka T
Nihon Rinsho; 2006 Jan; 64 Suppl 1():419-21. PubMed ID: 16457296
[No Abstract] [Full Text] [Related]
25. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers].
Capocasale E; Contini S; Rossetti A; Del Sante G; Gregori G
Acta Biomed Ateneo Parmense; 1985; 56(6):231-6. PubMed ID: 2940782
[TBL] [Abstract][Full Text] [Related]
26. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
Ławicki S; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
28. [Course of the serum determination of 4 tumor markers in viral hepatitis].
Coda C; Lanza E; Ciambellotti E; Cartia GL; Moro G
Minerva Med; 1987 Nov; 78(21):1577-81. PubMed ID: 3479707
[TBL] [Abstract][Full Text] [Related]
29. [Usefulness of tumor markers in the diagnosis of squamous carcinoma of the esophagus].
Pecchio F; Albertino B; Ferrarotti G; Baldi S; Adamo R; Lo Faso C; Oliaro A; Dei Poli M; Rapellino M
Minerva Chir; 1988 Sep; 43(18):1469-71. PubMed ID: 3226583
[No Abstract] [Full Text] [Related]
30. [Tumor marker and its clinical significance in diagnosis of colorectal cancer].
Imai Y
Nihon Rinsho; 2003 Sep; 61 Suppl 7():193-6. PubMed ID: 14574880
[No Abstract] [Full Text] [Related]
31. Serum CA 19-9 and CA 50 antigens in hemodialysis patients.
Docci D; Pistocchi E; Turci F; Baldrati L; Urbini S; Scaioli S
Clin Nephrol; 1987 Apr; 27(4):179-81. PubMed ID: 3472698
[TBL] [Abstract][Full Text] [Related]
32. [Combination assay of tumor markers in predicting the effectiveness of chemotherapy in non-small lung cancer].
Satoh H; Yano H; Suyama T; Hasegawa S
Gan To Kagaku Ryoho; 1992 Jan; 19(1):127-9. PubMed ID: 1346084
[No Abstract] [Full Text] [Related]
33. [Serial changes in serum CA 19-9 levels in pancreatic cancer].
Saito K; Tajiri H; Yoshimori M; Hijikata A; Ohkura H; Nakamura K; Ozaki H
Gan No Rinsho; 1987 Aug; 33(9):1057-60. PubMed ID: 3476762
[TBL] [Abstract][Full Text] [Related]
34. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.
Lai IR; Lee WJ; Huang MT; Lin HH
Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226
[TBL] [Abstract][Full Text] [Related]
35. [Tumor markers in the diagnosis of pancreatic carcinoma].
Lemma F; Bombardieri T; Salibra M; Trovato P; De Pasquale MC; Faraone V; Punturiero R; Di Mauro S
Minerva Med; 1989 Jul; 80(7):645-9. PubMed ID: 2779818
[No Abstract] [Full Text] [Related]
36. [Tumor markers in ovarian cancer].
Lahousen M
Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
[No Abstract] [Full Text] [Related]
37. Tumour markers in gastric cancer.
Roberts PJ; Haglund C; Onali M; Kuusela P
Ann Chir Gynaecol; 1989; 78(1):38-40. PubMed ID: 2667447
[TBL] [Abstract][Full Text] [Related]
38. [Tumor markers in the diagnosis and prognosis of breast cancer].
Seliuzhitskiĭ IV; Skvortsov SV; Lytsar BN; Khomenko LP
Klin Med (Mosk); 1993; 71(2):25-7. PubMed ID: 8046917
[TBL] [Abstract][Full Text] [Related]
39. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
40. [The relation between serum carcinoembryonic antigens (CEA) and response to chemotherapy in patients with advanced gastric cancer].
Saito D; Yoshida S; Hijikata A; Tajiri H; Yamaguchi H; Yoshimori M; Ohkura H; Okazaki N; Yoshida T; Yoshino M
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):948-57. PubMed ID: 3480325
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
